LOGICAL-INFORMATION MODEL OF EVALUATION THE IMPACT OF TARGETED THERAPy DRUGS ON THE BIOLOGICAL ACTIVITy OF CANCER CELLS

by V. V. Burlyaev, А. Davydenko, V. F. Kornyushko, L. I. Russu, M. Mezentseva
Published 2017-06-01

Correlation between clinical data and cytokines parameters in patients with Granulomatosis with Poilyangiitis (Wegener Granulomatosis)

by I. A. Lopatina, S. V. Moiseev, P. I. Novikov, L. I. Russu, E. I. Isaeva, M. V. Mezentseva
Published 2017-06-01

THE PROGNOSTIC MODEL OF ANTITUMOR EFFECT OF TARGETED DRUGS IN IMMUNOTHERAPY

by V. V. Burlyaev, А. А. Davydenko, O. M. Nikolaeva, L. I. Russu, I. A. Suetina, M. V. Mezentseva
Published 2016-08-01

EVALUATION OF THE EFFECT OF THE OPHTHALMIC REMEDIES COMBINATION ON THE VIABILITY OF HUMAN CONJUNCTIVAL CELL CULTURE CHANG CONJUNCTIVA

by I. A. Suetina, G. M. Chernakova, D. Yu. Maychuk, M. V. Mezentseva, L. I. Russu, E. A. Kleshcheva, S. M. Murtazalieva
Published 2017-12-01

In Vitro Study of Picloxidine 0.05 % Antiviral Activity (on the Example of Adenovirus)

by G. M. Chernakova, D. Yu. Maychuk, E. A. Klescheva, M. V. Mezentseva, L. I. Russu, I. A. Suetina, E. I. Isaeva
Published 2020-11-01

THE PERSPECTIVES OF DEVELOPMENT OF NEW PEPTIDE PREPARATIONS FOR CLINICAL USE WHICH HAVE ANTI-INFECTION AND IMMUNE-MODULATING ACTIVITY

by L. A. Andreeva, M. V. Mezentseva, A. N. Narovlianskiy, I. Ju. Nagaev, I. M. Shapoval, V. E. Scherbenko, L. I. Russu, N. F. Miasoedov
Published 2014-06-01